levetiracetam has been researched along with Birth-Weight* in 1 studies
1 other study(ies) available for levetiracetam and Birth-Weight
| Article | Year |
|---|---|
Efficacy of levetiracetam for neonatal seizures in preterm infants.
Neonatal seizures remain a significant clinical problem, and therapeutic options are still not diverse with limited efficacy. Levetiracetam (LEV) is a relatively new and wide spectrum anti-seizure medication with favorable pharmacokinetics and safety profile. In the recent decades, LEV has been increasingly used for the treatment of neonatal seizures. The aim of this study was to describe the experience of using LEV as the first line anti-seizure medication for preterm infants.. A retrospective analysis of 37 preterm infants who were treated with LEV as the first-line anti-seizure medication was performed.. Levetiracetam can be a good and safe choice for treatment of neonatal seizures in preterm infants. Prospective double blind controlled studies are needed in the future. Topics: Anticonvulsants; Birth Weight; Brain; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Levetiracetam; Magnetic Resonance Imaging; Male; Phenobarbital; Retrospective Studies; Seizures | 2018 |